Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.3650
-0.1550 (-29.81%)
At close: Nov 16, 2026, 4:00 PM EST
0.3700
+0.0050 (1.37%)
Pre-market: Nov 17, 2026, 7:43 AM EST
Milestone Pharmaceuticals Stock Forecast
MIST's stock price has decreased by -81.75% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 analysts polled by S&P Global, Milestone Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $3.86. The average 1-year stock price forecast is 956.71% higher than the current stock price, while the lowest is $1.00 (+173.97%) and the highest is $6.00 (+1,543.84%).
Price Target: $3.86 (+956.71%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Milestone Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +1,269.86% | Nov 16, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $3 | Buy | Maintains | $7 → $3 | +721.92% | Nov 16, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 → $6 | Buy | Reiterates | $8 → $6 | +1,543.84% | Nov 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $7 → $4 | Buy | Maintains | $7 → $4 | +995.89% | Nov 13, 2026 |
| Raymond James | Raymond James | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +1,269.86% | Oct 20, 2026 |
Financial Forecast
Revenue This Year
4.88M
from 1.55M
Increased by 215.89%
Revenue Next Year
12.55M
from 4.88M
Increased by 157.01%
EPS This Year
-0.79
from -0.75
EPS Next Year
-0.61
from -0.79
EPS and Forward PE are based on non-GAAP adjusted numbers.